Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$6.7M
-3.4% from 2023
Prescriptions
684
$9,773.32 per claim
Patients
125
103 prescribers
Total spending, 2024
$6.7M
$53,479.60 per patient
Medicare prescription drug plans paid $6.7M for Erbitux in 2024, for 684 prescriptions and refills to 125 patients (down 3.4% from 2023). The average cost per claim was $9,773.32.
New York had the highest Medicare cost for Erbitux in 2024: $2.0M for 157 claims, followed by California ($1.3M).
Gurmohan Syali, hematology-oncology in E Setauket, NY, had the highest Medicare cost for Erbitux in 2024: 21 claims costing $307K.
Erbitux is made by Eli Lilly and Company (LLY), listed in the Medicare spending data as Eli Lilly & Co..
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Gurmohan Syali E Setauket, NY | Hematology-Oncology | 21 | Under 11 | $307K |
| Manish Dhawan Minden, LA | Hematology-Oncology | 26 | Under 11 | $277K |
| Fabio Volterra |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 101 | 727 | 126 | $6.8M |
| 2023 | 92 | 710 | 110 | $6.9M |
| 2024 | 103 | 684 | 125 | $6.7M |
Spending by manufacturer as listed in the spending data
Amount reimbursed by state Medicaid programs, all states
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Hematology-Oncology |
| 20 |
| Under 11 |
| $220K |
| Azriel Hirschfeld Brooklyn, NY | Hematology-Oncology | 16 | Under 11 | $219K |
| Ahmed M Ali Washington, DC | Hematology-Oncology | 13 | Under 11 | $193K |
| Harsha Vyas Dublin, GA | Internal Medicine | 26 | Under 11 | $188K |
| Erole M McLean St Thomas, US | Hematology-Oncology | 14 | Under 11 | $182K |
| Bertrand Y Tuan San Francisco, CA | Hematology-Oncology | 23 | Under 11 | $174K |
| Adriana Guigova Port Jefferson Station, NY | Hematology-Oncology | 11 | Under 11 | $173K |
| John J Graham Canfield, OH | Hematology-Oncology | 21 | Under 11 | $161K |
| Antoine E Chahine Canfield, OH | Medical Oncology | 54 | Under 11 | $151K |
| Shahab A Khan Houston, TX | Hematology-Oncology | 27 | Under 11 | $141K |
| Hemalatha Vasireddy Belleville, NJ | Hematology-Oncology | 12 | Under 11 | $138K |
| Amer Rafiaa Brooklyn, NY | Hematology-Oncology | 11 | Under 11 | $137K |
| Delfino M Crescenzo Howard Beach, NY | Hematology-Oncology | 13 | Under 11 | $135K |
| Ravi K Patel Stuart, FL | Hematology-Oncology | 11 | Under 11 | $133K |
| Sujie Tang Sherman Oaks, CA | Hematology-Oncology | 16 | Under 11 | $98K |
| Jose E Abreu Arbelo San Juan, PR | Hematology-Oncology | 19 | Under 11 | $76K |
| Asit J Choksi The Woodlands, TX | Hematology-Oncology | 13 | Under 11 | $46K |
| Manufacturer | Claims | Spending |
|---|---|---|
| Eli Lilly & Co. LLY | 684 | $6.7M |